Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-06-010364
Filing Date
2006-08-04
Accepted
2006-08-04 07:28:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 a2172396z424b4.htm 424B4 979480
2 G140737.JPG g140737.jpg GRAPHIC 9382
  Complete submission text file 0001047469-06-010364.txt   993937
Mailing Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043
Business Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043 410-522-5005
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-134037 | Film No.: 061003736
SIC: 2836 Biological Products, (No Diagnostic Substances)